BACKGROUND: Adipose tissue expansion during obesity is associated with a state of low-grade inflammation and an increase in macrophage infiltration, which predisposes to insulin resistance and vascular malfunction. Growing evidence suggests that vitamin D 3 has immunoregulatory effects and adipose tissue could be a target for vitamin D 3 action. Preadipocytes, one of the major cell types in adipose tissue, are actively involved in inflammatory processes. OBJECTIVES: This study investigated whether the active form of vitamin D 3 (1,25(OH) 2 D 3 ) affects the production of proinflammatory chemokines/cytokines and the monocyte recruitment by human preadipocytes. METHODS/RESULTS: The secretion levels of monocyte chemoattractant proteint-1 (MCP-1), IL-8 and IL-6 were significantly higher in preadipocytes than in differentiated adipocytes, suggesting that preadipocytes could be a major source of proinflammatory mediators. Cytokine profile analysis revealed that 1,25(OH) 2 D 3 (10 nM) markedly reduced the release of MCP-1, IL-6 and IL-8 by preadipocytes. The involvement of NFkB signalling was shown by the upregulation of IkBa protein abundance by 1,25(OH) 2 D 3 in preadipocytes. In addition, 1,25(OH) 2 D 3 was able to decrease the migration of THP-1 monocytes. Treatment with proinflammatory stimuli, including macrophage-conditioned (MC) medium, TNFa and IL-1b, led to a marked increase in protein release of MCP-1 and IL-6 by preadipocytes. Pretreatment with 1,25(OH) 2 D 3 (10 nM and 100 nM) significantly decreased the stimulatory effects of MC medium, TNFa and IL-1b on MCP-1 expression and protein release, although the effect on stimulated release of IL-6 was less potent. CONCLUSIONS: These results demonstrate that 1,25(OH) 2 D 3 decreases the production of MCP-1 and other proinflammatory mediators by preadipocytes and reduces monocyte migration. Thus, vitamin D 3 may protect against adipose tissue inflammation by disrupting the deleterious cycle of macrophage recruitment.
INTRODUCTION
White adipose tissue expansion during obesity is accompanied by increased infiltration of macrophages, and this is associated with a state of low-grade inflammation. 1, 2 As an endocrine organ, adipose tissue secretes a number of protein factors that are directly involved in inflammation. 3 The expression and release of some of these factors, including TNFa, IL-6, monocyte chemoattractant proteint-1 (MCP-1) and IL-8, have been shown to be elevated in obesity. [4] [5] [6] Studies have suggested that the stromal-vascular fraction of adipose tissue is a major source of the production of proinflammatory factors in comparison with the mature adipocytes. 7 Preadipocytes, a major component of the stromal-vascular fraction, have been shown to function as macrophage-like cells and produce proinflammatory mediators. 8, 9 Recent studies from our group and others have demonstrated that the release of MCP-1, IL-8 and IL-6 by human preadipocytes was substantially increased in response to the stimulation by macrophage-conditioned (MC) medium. 9, 10 Therefore, preadipocytes could be a key factor in adipose tissue inflammation in obesity. The vitamin D system is increasingly recognised to have a range of physiological functions beyond calcium homeostasis and bone metabolism. 11 The major circulating form of vitamin D is 25-hydroxycholecalciferol (25(OH)D 3 ), which is converted to the biologically active factor, 1,25-dihydroxycholecalciferol (1,25(OH) 2 D 3 ). The actions of 1,25(OH) 2 D 3 are mediated through the vitamin D receptor that modulates the transcription of a number of target genes. 11 Growing evidence suggests that 1,25(OH) 2 D 3 has immunoregulatory effects, such as modulating T-lymphocyte proliferation and function, 12 and suppressing the production of inflammatory cytokines, chemokines and prostaglandins in cancer cells. 13, 14 These actions of vitamin D may be through inhibiting the p38 MAPK 15 and NF-kB signalling. [16] [17] [18] Clinical studies on vitamin D status in humans have suggested that there is a link between vitamin D deficiency and obesity. 19, 20 Serum levels of 25(OH)D 3 are inversely correlated with body mass index and body fat mass in both children and adults. 21, 22 There is also evidence from healthy subjects that lower levels of serum 25(OH)D 3 are associated with an increase in systemic inflammation. 23 The extent to which there is a role of vitamin D in adipose tissue function is not well understood. However, 1,25(OH) 2 D 3 has been shown to inhibit the differentiation of 3T3-L1 cells and of porcine preadipocytes, and to repress the expression of adipogenic transcription factor genes. 24, 25 A recent study has also shown that 1,25(OH) 2 D 3 decreased the TNFastimulated expression and release of MCP-1 and adiponectin by differentiated human adipocytes. 26 Although preadipocytes are important in adipose tissue inflammation, it is not known whether vitamin D modulates the inflammatory response in these precursor cells.
The present study has investigated the effect of 1,25(OH) 2 D 3 on the production of proinflammatory chemokines/cytokines by human preadipocytes, with or without the stimulation of macrophage-derived factors. The study has also examined whether vitamin D 3 acts on the NFkB signalling pathway in human preadipocytes. Finally, the effect of 1,25(OH) 2 D 3 on monocyte migration has been explored.
MATERIALS AND METHODS

Culture of human preadipocytes
Human white preadipocytes derived from subcutaneous adipose tissue of a female Caucasian subject (body mass index 21; age 44 years) were obtained from PromoCell (Heidelberg, Germany). Preadipocytes were cultured in preadipocyte growth medium supplemented with 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin and 0.25 mg ml À 1 amphotericin B (Lonza, Tewkesbury, UK) at 37 1C in a humidified atmosphere of 5% CO 2 / 95% air. Preadipocytes were seeded onto 6-well or 24-well plates and grown until confluence. At confluence, cells were induced to differentiate (day 0) by incubation for 3 days in Dulbecco's Modified Eagle's Medium/ Ham's F12 (1:1) medium containing 32 mM biotin,1 mM dexamethasone, 200 mM 3-isobutyl-1-methyl-xanthine, 100 nM insulin, 11 nM l-Thyroxine (all from Sigma, Poole, UK), 8 mM rosiglitazone (GlaxoSmithKline, Uxbridge, UK), and 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin and 0.25 mg ml À 1 amphotericin B. After induction, cells were further maintained in feeding medium containing 3% fetal calf serum (Sigma), 100 nM insulin, 32 mM biotin and 1 mM dexamethasone until full differentiation. Differentiation into adipocytes was confirmed by observing the accumulation of lipid droplets under the microscope.
Culture of THP-1 monocytes
The human THP-1 monocytic cell line was kindly provided by Professor Helen R Griffiths (Aston University, UK). Human THP-1 monocytes (1 Â 10 6 cells ml À 1 ) were cultured in 24-well plates in Roswell Park Memorial Institute (RPMI-1640) medium with 10% fetal calf serum and 100 U ml À 1 penicillin, 100 mg ml À 1 streptomycin, and 0.25 mg ml À 1 amphotericin B at 37 1C. To prepare MC medium, THP-1 monocytes were first differentiated by the addition of 100 nM phorbol 12-myristate 13-acetate (PMA; Sigma) for 48 h. The medium was then replaced with fetal calf serum-free RPMI-1640 medium (without PMA) for 24 h, and this conditioned (MC) medium was then harvested, filtered through a 0.22-mm filter and stored at À 80 1C for later use.
Cell culture treatment
To assess the effect of vitamin D on cytokine secretion profile, preadipocytes were treated with 1,25(OH) 2 D 3 (10 nM) (ENZO Life Sciences, Plymouth Meeting, PA, USA) for 24 h, and the control group of preadipocytes received no treatment. To further investigate whether vitamin D inhibits the effects of proinflammatory stimuli on cytokine/ chemokine production, the cells were preincubated with vitamin D 3 (10 and 100 nM) for 24 h and then treated with either MC medium, TNFa (5 ng ml À 1 ) or IL-1b (5 ng ml À 1 ) in the presence of vitamin D 3 (10 and 100 nM) for further 24 h.
To examine whether TNFa and IL-1b mediate the effects of MC medium on the expression and release of MCP-1 and IL-6, MC medium was preincubated with human TNFa or IL-1b neutralising antibody (all from R&D Systems, Abingdon, UK) or mouse IgG (Sigma) as negative controls (1 or 15 mg/ml) for 1 h. Preadipocytes were then treated with RPMI-1640 medium (control), MC medium, TNFa-neutralised MC medium, IL-1bneutralised MC medium or MC medium neutralised by both TNFa (7.5 mg ml À 1 ) and IL-1b (7.5 mg ml À 1 ) antibodies for 24 h.
To elucidate the potential signalling pathway, preadipocytes were preincubated with vitamin D 3 (10 and 100 nM) for 24 h at 37 1C.
At the end of each experiment, cells and the culture media were collected and stored at À 80 1C until analysis.
Measurement of MCP-1, IL-8 and IL-6 release
Protein release of MCP-1, IL-8, IL-6, adiponectin and leptin by preadipocytes and adipocytes was measured as the protein concentrations in cell culture medium, using human ELISA kits (R&D Systems).
Cytokine protein array
Preadipocytes were pretreated with 10 nM vitamin D 3 for 24 h, or without treatment, as controls. The cell culture medium (n ¼ 6 per group) was harvested 24 h later and pooled. The samples were incubated with a cocktail of biotinylated detection antibodies for 1 h at room temperature and followed by the incubation with a human cytokine array (panel A) (R&D Systems) overnight at 4 1C. The array was then incubated with streptavidin-horseradish peroxidase and the protein signals were detected by chemiluminescence (West Pico kit, Pierce, Loughborough, UK) and captured by Molecular Imager ChemiDoc XRS þ System (Bio-Rad, Hertfordshire, UK). The detected signals were then quantified as pixel density according to the manufacturer's instructions.
Transmigration assay
THP-1 monocytes were suspended in RPMI-1640 (serum-free) at 2 Â 10 6 ml and added to the top chamber of HTS transwells (Fisher Scientific, Loughborough, UK). Preadipocytes were treated with or without vitamin D 3 (10 and 100 nM) for 24 h; the medium was harvested and added to the lower chamber of transwells. In addition, the medium of untreated preadipocytes with freshly added vitamin D 3 (10 nM) or preadipocyte growth medium alone (without cells) was added to the lower chamber of transwells. After incubation for 4 h at 37 1C, the number of monocytes that had migrated to the lower chamber was determined by the MTT assay using a cell density standard curve.
Western blotting
Total cellular protein was prepared by lysing cells in lysis buffer (50 mM Tris-HCl pH 6.7, 10% glycerol, 4% SDS, 2% 2-mercaptoethanl) with freshly added protease inhibitor cocktail and phosphatase inhibitor cocktail (both from Sigma). Protein concentrations were determined by the BCA method. Protein samples (20 mg per lane) were resolved by 10% Tricine-SDS polyacrylamide slab gels (Mini Protean Tetra, Bio-Rad, Hemel Hempstead, UK), transferred onto a nitrocellulose membrane (Hybond C Extra, Amersham Bioscience, Little Chalfont, UK) by wet transfer (Trans Blot, Bio-Rad) at 100 V for 1 h. The transfer of proteins onto the membrane was assessed by Ponceau S staining.
For immunodetection, the membrane was blocked for 1 h at room temperature with Tris-buffered saline (TBS) containing 0.1% Tween 20 and 5% non-fat milk and incubated overnight at 4 1C with an antibody for IkBa (New England BioLabs Ltd, Hitchin, UK) at a 1:1000 dilution in 5% non-fat milk TBS and 0.1% Tween-20 followed by an anti-mouse secondary antibody (Bio-Rad) at 1:2000 dilution. Signals were detected by chemiluminescence (West Pico kit, Pierce) and scanned using Molecular Imager ChemiDoc XRS þ System (Bio-Rad). The size of the protein bands detected was estimated with PageRuler protein markers (Fermentas, York, UK). Subsequently, the membrane was further probed with the antibody detecting a-tubulin as a loading control.
Real-time PCR
Total RNA was extracted from cells using Trizol (Invitrogen, Paisley, UK) and the RNA concentration determined from the absorbance at 260 nm. First strand cDNA was reverse transcribed from 0.5 mg of total RNA using an iScript first strand synthesis kit (Bio-Rad) in a final volume of 10 ml. Realtime PCR amplification was performed in a final volume of 12.5 ml, containing cDNA (equivalent to 10 ng of RNA), optimised concentrations of primers, TaqMan probe (FAM-TAMRA) and a master mix made from qPCR core kit (Eurogentec, Seraing, Belgium) using a Stratagene Mx3005P instrument (Agilent Technologies, Santa Clara, CA, USA). The sequences of primers and probes for human b-actin, IL-6, MCP-1 and IL-8 were as described previously. 27, 28 PCR amplification was performed in duplicate and the PCR cycling conditions were as follows: 95 1C for 10 min followed by 40 cycles (95 1C for 15 sec, 60 1C for 1 min). Blank controls without cDNA Vitamin D 3 inhibits inflammation in preadipocytes D Gao et al were run in parallel. b-Actin was used as a reference gene. All samples were normalised to the b-actin values and the results expressed as fold changes of Ct value relative to controls using the 2 À DDct formula. 29 
Cell viability assay
To assess cell viability following various treatments, cells were incubated with 100 ml 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) (Sigma) solution (5 mg ml À 1 in phosphate-buffered saline) for 4 h at 37 1C. Lysis buffer (100 ml; 20% SDS in 50% dimethyl formamide, pH 4.7) was added to each well and the cells were incubated for a further 16 h at 37 1C. The absorbance was read at 570 nm using a spectrophotometer (Bio-Rad) at room temperature.
Statistical analysis
Data are expressed as means ± s.e.m. Differences between two groups were analysed by Student's unpaired t-test; ANOVA was employed for multi-group comparisons. Differences were considered as statistically significant when Po0.05.
RESULTS
MCP-1, IL-8 and IL-6 are secreted mainly by human preadipocyte In initial experiments, the release of chemokines and cytokines by preadipocytes was examined. Measurements by ELISA indicate that preadipocytes are a more important source of the production of the chemokines MCP-1, IL-8 and of the cytokine IL-6 than adipocytes (Figure 1a -c). The levels of the chemokines/cytokines were significantly higher in the medium from preadipocytes (D0) compared to differentiated adipocytes (D9); MCP-1 was increased by 10-fold (Po0.001), IL-8 by 82-fold (Po0.001) and IL-6 by 5-fold (Po0.001) in the preadipocyte medium relative to the adipocyte medium. However, IL-1b was undetectable in cell culture medium from both cell types (data not shown). In contrast, the adipokines, adiponectin and leptin were exclusively secreted by adipocytes (Figure 1d -e).
Vitamin D 3 decreases the protein release of MCP-1, IL-8 and IL-6 by human preadipocytes To explore the potential effect of vitamin D 3 on the secretion profile of chemokines/cytokines by preadipocytes, a cytokine protein array was used. As shown in Figure 2a -b, seven proteins (G-CSF, GROa, IL-6, IL-8, MCP-1, MIF and PAI-1) were detected in the medium from preadipocytes, both in the presence and absence of 1,25(OH) 2 D 3 . Quantification of the spots on the arrays by densitometry indicated that treatment with 1,25(OH) 2 D 3 (10 nM) reduced the release of MCP-1, IL-8 and IL-6, compared with controls, and there was a slight reduction in G-CSF, MIF and PAI-1 release (Figure 2c ). The reduction in MCP-1 and IL-6 release was confirmed by ELISA. Treatment with 1,25(OH) 2 D 3 (10 and 100 nM) resulted in a dose-dependent decrease in MCP-1 (twofold and threefold, both Po0.001) and IL-6 (10 and 40%, both Po0.01) in the medium compared to controls (Figures 2d and e ).
Vitamin D inhibits activation of NF-kB signalling pathway As NF-kB activation is central in the signal transduction of proinflammatory cytokines, we next examined whether the effect of vitamin D 3 on chemokine/cytokine production could be through inhibition of NF-kB in preadipocytes. As shown in Further, addition of fresh 1,25(OH) 2 D 3 (10 nM) to the control medium decreased monocyte migration (by 25%, Po0.001); preadipocyte growth medium alone (without cells) caused the least migration of monocytes (Figure 3c ).
TNFa and IL-1b neutralization inhibits the induction of MCP-1 and IL-6 in human preadipocytes by MC medium In the next experiments, whether TNFa and IL-1b have a key role in mediating the effects of MC medium on the expression of proinflammatory mediators by preadipocytes was examined. This was performed by assessing whether neutralising TNFa or IL-1b activity using specific antibodies antagonises the effect of MC medium on the expression of MCP-1 and IL-6. As shown in Figures  4a and b) , incubation of preadipocytes in the presence of MC medium led to a marked increase in mRNA levels for both MCP-1 (23-fold, Po0.001) and IL-6 (1710-fold, Po0.001), compared to controls maintained in unconditioned medium. Inhibition of TNFa or IL-1b significantly reduced, in a dosedependent manner, the induction of MCP-1 and IL-6 gene and anti-IL-1b antibodies (7.5 mg ml À 1 ) almost completely attenuated the induction of MCP-1 and IL-6 by MC medium (Figures  4a and b) . The specificity of the TNFa and IL-1b neutralising antibodies was confirmed by there being no significant differences in expression levels of MCP-1 and IL-6 between preadipocytes treated with MC medium and MC medium preincubated with mouse IgG (1 or 15 mg ml À 1 ; Figures 4a and b ).
Vitamin D 3 reduces the induction of chemokines/cytokines in preadipocytes by MC medium
As macrophage-derived factors potently stimulate inflammatory responses in preadipocytes, the effects of vitamin D 3 on MC medium-induced production of chemokines/cytokines by preadipocytes were examined. As shown in Figure 5a -d, exposure to MC medium (100%) for 24 h dramatically increased mRNA levels of MCP-1 (27-fold, Po0.001), IL-8 (87-fold, Po0.001), IL-1b (1850-fold, Po0.001) and IL-6 (1403-fold, Po0.001) compared to controls. Consistent with the mRNA data, the MC medium substantially increased the release of MCP-1 (12-fold, Po0.001) and IL-6 (584fold, Po0.001) compared to controls (Figures 5f and g) .
Preincubation of preadipocytes with 1,25(OH) 2 D 3 (10 and 100 nM) decreased the MC medium-induced gene expression of MCP-1 (2-fold and 3-fold, both Po0.01), IL-8 (both 1.7-fold, both Po0.05) and IL-1b (4.9-fold and 3.7-fold, both Po0.001) ( Figures  5a-c) . However, no significant (P40.05) effect of 1,25(OH) 2 D 3 was found on MC-induced IL-6 gene expression (Figure 5d ). At the level of protein secretion, 1,25(OH) 2 D 3 (10 and 100 nM) led to a reduction in MC medium-stimulated MCP-1 release (12 and 13%, both Po0.01) (Figure 5e ), but had no effect on IL-6 release (Figure 5f ). The different scale of change in mRNA level and protein release for MCP-1 and IL-6 is likely to be due to differences in time-course; the mRNA level relates to the point at which the cells are taken, whereas the protein release is the aggregate of the whole time-course of the experiment.
Vitamin D 3 reduces TNFa and lL-1b-induced MCP-1 production by human preadipocytes As TNFa and IL-1b mediate the MC medium-induced release of MCP-1 and IL-6 by human preadipocytes, we further investigated whether vitamin D 3 can antagonise the cytokine-stimulated inflammatory response in preadipocytes. As shown in Figures 6a  and b , TNFa significantly increased the release of MCP-1 (13.5-fold, Po0.001) and IL-6 (11-fold, Po0.001) by preadipocytes. Pretreatment with 1,25(OH) 2 D 3 (10 and 100 nM) significantly reduced MCP-1 release (40 and 27%, both Po0.001) induced by TNFa (Figure 6a ), but there was no inhibition of IL-6 release (Figure 6b ). IL-1b substantially increased MCP-1 (28-fold, Po0.001) and IL-6 (656-fold, Po0.001) release from preadipocytes (Figures 6c and d) . Importantly, preincubation with 1,25(OH) 2 D 3 (10 and 100 nM) significantly reduced MCP-1 (36 and 33%, both Po0.001) and IL-6 (38 and 43%, both Po0.001) release stimulated by IL-1b.
Vitamin D 3 does not affect preadipocyte viability Finally, the MTT assay for cell viability was conducted in parallel and showed that none of the treatments employed in this study affected cell viability (Supplementary Figure S1a-d) .
DISCUSSION
White adipose tissue as an active endocrine organ secretes a range of protein factors, including those involved in inflammation and inflammatory responses. 3, 30 However, studies have suggested that the non-fat cells within adipose tissue are the major source of production of proinflammatory factors. 7 In the present study, the basal release of proinflammatory chemokines/cytokines, such as MCP-1, IL-8 and IL-6, primarily occurred in preadipocytes compared with differentiated human adipocytes. We also demonstrate that under the stimulation of macrophage-derived factors, specifically TNFa and IL-1b, there was a considerable increase in the expression and release of these factors. Lipopolysaccharide has also been shown to induce a major increase in the mRNA level of proinflammatory cytokines (IL-6, TNFa and IL-1b) and chemokines (MCP-1 and IL-8) in human preadipocytes, leading to a decrease in PPARg activity and insulinstimulated glucose uptake in adipocytes. 31 Furthermore, the gene expression profile of preadipocytes has been shown to be closer to that of macrophages than to adipocytes, and preadipocytes can acquire high phagocytic activity when in contact with peritoneal macrophages. 32 Collectively, it is suggested that preadipocytes are a major site of the production of proinflammatory chemokines/ cytokines within adipose tissue, thereby having a key role in adipose inflammation in obesity.
The emerging role of vitamin D 3 in immune regulation suggests that this endocrine factor may modulate the inflammatory responses in adipose tissue. We demonstrate in this study that 1,25(OH) 2 D 3 (10 nM) significantly reduced the basal release of MCP-1, IL-8 and IL-6 from preadipocytes. It should be noted that the doses of 1,25(OH) 2 D 3 employed in the present work are similar to those used in several other studies, 33 including a recent publication that showed that 1,25(OH) 2 D 3 (100 nM) is effective in modulating MCP-1 and adiponectin production by human adipocytes. 26 It should also be pointed out that as adipocytes store vitamin D, and adipocytes as well as monocytes/macrophages are able to locally convert 25(OH)D 3 to 1,25(OH) 2 D 3 , 34, 35 the concentrations of vitamin D within adipose tissue could be higher than implied by the plasma levels. Further studies are required to determine the exact levels of vitamin D in obese adipose tissue.
The chemokine MCP-1 and its receptor CCR2 have been reported to be critical factors in promoting the recruitment of monocytes into adipose tissue. 36 The release of MCP-1 by adipose tissue and the circulating levels of MCP-1 are elevated during the development of obesity. 7, 37 Moreover, MCP-1 is also produced by macrophages 38 that increase further macrophage infiltration into adipose tissue, which may lead to a vicious cycle of monocyte recruitment. IL-8, a member of the CXC chemokine family, has been shown to be responsible for the recruitment of neutrophils into tumour tissue. 39 Circulating levels of IL-8 are increased in obese subjects. 40 It has been reported that in the early stage of high-fat diet feeding in mice, there is a transient increase in neutrophil infiltration in abdominal adipose tissue and this was partially attributed to IL-8. 41 The signalling pathways that are involved in the action of vitamin D 3 in adipose tissue remain to be clarified. NF-kB activation is crucial in the signal transduction of proinflammatory cytokines, and NF-kB knockdown reverses the upregulation of IL-6 gene expression in preadipocytes. 42 The activation of NF-kB signalling involves the degradation of IkBa protein and translocation of p65 into the nucleus. 43 In the present study, we show that 1,25(OH) 2 D 3 increased IkBa protein expression in preadipocytes and this suggests that vitamin D 3 may inhibit the activation of NF-kB signalling, probably by increasing the stability of IkBa protein. Similar to our results, previous studies have reported that in murine macrophages, human fibroblasts and peripheral blood mononuclear cells, vitamin D 3 is able to stabilise IkBa protein, which inhibited p65 translocation to the nucleus and subsequently reduced NFkB activity. [16] [17] [18] 44 Furthermore, in mesangial cells 1,25(OH) 2 D 3 suppresses high glucose-induced MCP-1 expression and promoter activity by blunting NFkB activation. 45 In parallel with the effects of vitamin D 3 on chemokine production, the present study demonstrates that vitamin D 3 has an inhibitory effect on the chemoattractant properties of preadipocytes as pretreatment with 1,25(OH) 2 D 3 (10 nM and 100 nM) reduced monocyte migration. As 1,25(OH) 2 D 3 has a short half-life of 15 h, 46 the reduction in THP-1 cell migration induced by preadipocytes could be, at least in part, the result of the inhibitory effect of vitamin D 3 on MCP-1 release. In addition, we show that Vitamin D 3 inhibits inflammation in preadipocytes D Gao et al 1,25(OH) 2 D 3 alone also led to an inhibition on monocyte migration. These observations are novel, which suggests that vitamin D 3 could be anti-inflammatory in human adipose tissue, reducing the basal release of MCP-1 and other proinflammatory factors by preadipocytes and limiting the infiltration of immune cells.
With the expansion of adipose tissue in obesity, there is an increased infiltration of immune cells, especially macrophages. 47 There are two types of macrophages in adipose tissue: the classically activated M1 type and the alternatively activated M2 type. 48 The newly recruited macrophages in adipose tissue in obesity are mainly derived from bone marrow and exhibit the M1 phenotype, 48 which secrete a variety of cytokines such as TNFa and IL-1b. 48 We show in this study that MC medium potently induces the upregulation of MCP-1 and IL-6 in preadipocytes, and that this is largely mediated by TNFa and IL-1b. Blocking TNFa and IL-1b with the neutralising antibody attenuated the elevation of MCP-1 and IL-6 mRNA elicited by MC medium (Figure 4 ). Therefore, TNFa and IL-1b are likely to be the primary mediators of the effects of macrophages on MCP-1 and IL-6 production in preadipocytes.
Although vitamin D 3 has been shown to downregulate the expression of proinflammatory cytokines/chemokines (TNFa, IL-6, IL-1 and IL-8) in human monocytes stimulated with IFN-g, 49 little is known on whether vitamin D 3 acts similarly in human adipose cells challenged by inflammatory stimuli. A key finding of the present study is the demonstration that 1,25(OH) 2 D 3 was able to reduce the overexpression and release of MCP-1 induced by MC medium in preadipocytes (Figures 5a and e ). In addition, our data also show that 1,25(OH) 2 D 3 effectively inhibited the increase in MCP-1 release induced by TNFa or IL-1b (Figures 6a and c) , suggesting that vitamin D 3 has a protective role in restraining the inflammatory response in preadipocytes. Although there is a lack of data on the effects of vitamin D 3 on preadipocytes, a recent study using mature human adipocytes has reported an inhibitory effect of 1,25(OH) 2 D 3 on TNFa-elicited MCP-1 production. 26 As shown by the present study, 1,25(OH) 2 D 3 decreased the IL-1bstimulated release of IL-6, but had no effect on the induction by MC medium and TNFa. This may suggest that vitamin D 3 could be more effective in the reduction of chemokine production by preadipocytes under stimulated conditions.
In summary, this study demonstrates that human preadipocytes abundantly secrete proinflammatory proteins, and 1,25(OH) 2 D 3 significantly decreased the release of MCP-1, IL-8 and IL-6 from preadipocytes. The effects of vitamin D 3 may be through the inhibition of NFkB activation as 1,25(OH) 2 D 3 upregulated IkBa protein abundance in preadipocytes. Furthermore, 1,25(OH) 2 D 3 exhibits an inhibitory effect on THP-1 monocyte migration induced by preadipocytes. Importantly, pretreatment with 1,25(OH) 2 D 3 ameliorated the stimulatory effect of MC medium, TNFa and IL-1b on MCP-1 expression and protein release by preadipocytes. Our results suggest that vitamin D 3 may protect against adipose tissue inflammation in obesity, at least in part, by lowering the release of MCP-1 and other proinflammatory mediators from preadipocytes and disrupting the vicious cycle of macrophage recruitment. Figure 6 . Effects of vitamin D 3 on TNFa-or IL-1b-induced MCP-1 and IL-6 protein release by preadipocytes. Preadipocytes were preincubated with vitamin D 3 (10 and 100 nM) for 24 h and then treated with TNFa (5 ng ml À 1 ) or IL-1b (5 ng ml À 1 ) for another 24 h in the presence of vitamin D 3 . Protein levels of MCP-1(a-c) and IL-6 (b-d) release were measured by ELISA. Data are means±s.e.m. for groups of six; ***Po0.001. The results were verified by three independent experiments.
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